Zurich Cantonal Bank
FUSN

Zurich Cantonal Bank’s Fusion Pharmaceuticals Inc. Common Shares FUSN Stock Holding History

Zurich Cantonal Bank’s Portfolio FUSN Stock Details FUSN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-5,252
Closed -$112K – 2736
2024
Q1 		$112K Buy
+5,252
New +$62.8K ﹤0.01% 2344

Zurich Cantonal Bank's FUSN Position: Q2 2024 in Review

Zurich Cantonal Bank sold out of Fusion Pharmaceuticals Inc. Common Shares (FUSN) in Q2 2024, closing a stake of 5,252 shares — an estimated $112K sold.

Zurich Cantonal Bank first reported a position in FUSN in Q1 2024 and held it in 1 quarter. The position peaked at $112K in Q1 2024. 0 funds tracked by Wall St. Rank hold FUSN as of Q2 2024.

  • Zurich Cantonal Bank reported no remaining Fusion Pharmaceuticals Inc. Common Shares position as of Q2 2024 after selling out during the quarter.
  • Zurich Cantonal Bank sold 5,252 Fusion Pharmaceuticals Inc. Common Shares shares in Q2 2024, an estimated $112K.
  • Zurich Cantonal Bank first reported a position in Fusion Pharmaceuticals Inc. Common Shares in Q1 2024 and held it in 1 quarter.
  • Zurich Cantonal Bank's Fusion Pharmaceuticals Inc. Common Shares position peaked at $112K in Q1 2024.
  • 0 funds tracked by Wall St. Rank held Fusion Pharmaceuticals Inc. Common Shares as of Q2 2024.

Based on Zurich Cantonal Bank's 13F filing for Q2 2024, filed 29 Jul 2024.